Literature DB >> 33509194

Adherence predictor variables in AIDS patients: an empirical study using the data mining-based RFM model.

Min Li1,2, Qunwei Wang2, Yinzhong Shen3.   

Abstract

BACKGROUND: Highly active antiretroviral therapy (ART) is still the only effective method to stop the disease progression in acquired immunodeficiency syndrome (AIDS) patients. However, poor adherence to the therapy makes it ineffective. In this work, we construct an adherence prediction model of AIDS patients using the classical recency, frequency and monetary value (RFM) model in the data mining-based customer relationship management model to obtain adherence predictor variables.
METHODS: We cleaned 257,305 diagnostic data elements of AIDS outpatients in Shanghai from August 2009 to December 2019 to obtain 16,440 elements. We tested the RFM and RFm (R: recent consultation month, F: consultation frequency, M/m: total/average medical costs per visit) models, three clustering methods (K-means, Kohonen and two-step clustering) and four decision algorithms (C5.0, the classification and regression tree, Chi-square Automatic Interaction Detector and Quick, Unbiased, Efficient, Statistical Tree) to select the optimal combination. The optimal model and clustering analysis were used to divide the patients into two groups (good and poor adherence), then the optimal decision algorithm was used to construct the prediction model of adherence and obtain its predictor variables.
RESULTS: The results revealed that the RFm model, K-means clustering analysis and C5.0 algorithm were optimal. After three rounds of k-means clustering analysis, the optimal RFm clustering model quality was 0.8, 10,614 elements were obtained, including 9803 and 811 from patients with good or poor adherence, respectively, and five types of patients were identified. The prediction model had an accuracy of 100% with the recent consultation month as an important adherence predictor variable.
CONCLUSIONS: This work presented a prediction model for medication adherence in AIDS patients at the designated AIDS center in Shanghai, using the RFm model and the k-means and C5.0 algorithms. The model can be expanded to include patients from other centers in China and worldwide.

Entities:  

Keywords:  AIDS; Adherence prediction; Antiretroviral therapy; RFM

Year:  2021        PMID: 33509194      PMCID: PMC7842065          DOI: 10.1186/s12981-020-00326-8

Source DB:  PubMed          Journal:  AIDS Res Ther        ISSN: 1742-6405            Impact factor:   2.250


  32 in total

1.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

2.  Multi-level Determinants of Clinic Attendance and Antiretroviral Treatment Adherence Among Fishermen Living with HIV/AIDS in Communities on Lake Victoria, Uganda.

Authors:  K M Sileo; R K Wanyenze; W Kizito; E Reed; S K Brodine; H Chemusto; W Musoke; B Mukasa; S M Kiene
Journal:  AIDS Behav       Date:  2019-02

3.  Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.

Authors:  Maya L Petersen; Erin LeDell; Joshua Schwab; Varada Sarovar; Robert Gross; Nancy Reynolds; Jessica E Haberer; Kathy Goggin; Carol Golin; Julia Arnsten; Marc I Rosen; Robert H Remien; David Etoori; Ira B Wilson; Jane M Simoni; Judith A Erlen; Mark J van der Laan; Honghu Liu; David R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

4.  Patient Relationship Management: What the U.S. Healthcare System Can Learn from Other Industries.

Authors:  Michael K Poku; Nima A Behkami; David W Bates
Journal:  J Gen Intern Med       Date:  2016-08-08       Impact factor: 5.128

5.  Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.

Authors:  Alexis A Krumme; Gabriel Sanfélix-Gimeno; Jessica M Franklin; Danielle L Isaman; Mufaddal Mahesri; Olga S Matlin; William H Shrank; Troyen A Brennan; Gregory Brill; Niteesh K Choudhry
Journal:  BMJ Open       Date:  2016-11-09       Impact factor: 2.692

6.  Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal.

Authors:  Sujan Neupane; Govinda Prasad Dhungana; Harish Chandra Ghimire
Journal:  BMC Public Health       Date:  2019-06-10       Impact factor: 3.295

7.  Prevalence and determinants of adherence to antiretroviral treatment among HIV patients on first-line regimen: a cross-sectional study in Dakar, Senegal.

Authors:  Mouhamed Abdou Salam Mbengue; Serigne Omar Sarr; Aissatou Diop; Cheikh Tidiane Ndour; Bara Ndiaye; Souleymane Mboup
Journal:  Pan Afr Med J       Date:  2019-06-10

8.  Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.

Authors:  Tamrat Endebu; Alem Deksisa; Warku Dugasa; Ermiyas Mulu; Tilahun Bogale
Journal:  BMC Public Health       Date:  2019-10-21       Impact factor: 3.295

9.  [Compliance with the partner notification of HIV/STI patients in the counties of Lleida].

Authors:  Álvaro Vilela; Pilar Bach; Pere Godoy
Journal:  Rev Esp Salud Publica       Date:  2019-12-02

10.  Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.

Authors:  Jessica E Haberer; Lora Sabin; K Rivet Amico; Catherine Orrell; Omar Galárraga; Alexander C Tsai; Rachel C Vreeman; Ira Wilson; Nadia A Sam-Agudu; Terrence F Blaschke; Bernard Vrijens; Claude A Mellins; Robert H Remien; Sheri D Weiser; Elizabeth Lowenthal; Michael J Stirratt; Papa Salif Sow; Bruce Thomas; Nathan Ford; Edward Mills; Richard Lester; Jean B Nachega; Bosco Mwebesa Bwana; Fred Ssewamala; Lawrence Mbuagbaw; Paula Munderi; Elvin Geng; David R Bangsberg
Journal:  J Int AIDS Soc       Date:  2017-03-22       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.